Thermo Fisher Scientific: The Innovation Powerhouse in Life Sciences
If scientific knowledge is the chauffeur to advance the human race, engineered tools and machines have been the wheels of this advancement. It is like a tightly connected cycle—as better scientific understanding enables humanity to build futuristic instruments, those tools, in turn, become the very harpoons to enhance what we know and build further. Thermo Fisher Scientific, one of the world’s largest scientific instruments and biological research solution providers, has been proving this point more than anyone else with innovations in the life sciences industry. Founded in 2006 through the merger of Thermo Electron and Fisher Scientific, the company is a one-stop shop for multiple biological research enterprises, biopharmaceutical companies, healthcare institutions, and other life sciences firms of all sizes around the globe.
John Rontree, Senior Director of Marketing, Thermo Fisher Scientific, when asked about the major challenges gnawing in the market today says, “With the massive growth in the biotherapeutic market, scientists are challenged with increasing analytical complexity due to the advent of potent monoclonal antibodies such as Antibody Drug Congugates and Bi-Specifics.
The company is a one-stop shop for multiple biological, bio-pharmaceutical companies, healthcare institutions, and other life sciences firms of all sizes around the globe
This requires us to build more sophisticated instrument platforms which we can build into workflow solutions to facilitate biologists in their decision making processes.”
Thermo Fisher Scientific, renowned as one of the biggest innovative forces in the domain, offers all products that a client might need along the entire bio-production chain, addressing the specialized requirements of both complex research and rugged QA-QC testing. Rontree specifically highlights the company’s efforts in two key disruptive technologies for the industry today—mass spectrometry and chromatography. While chromatography is a fundamental tool for domain analysts to separate biomolecules for deeper inspection, mass spectrometry has been one of the most promising and widely-adopted techniques in dealing with complex biomolecule characterizations. Thermo Fisher Scientific has made these technologies seamlessly adaptable to both advanced research and QA-QC environments, while greatly enhancing the technologies’ productivity, efficiency, and ROI performance.
For Rontree, data and cloud, will play a significant role for Thermo Fisher Scientific in the near future. The company focuses on more innovative life sciences products in association with cloud-data technologies to deepen information analysis, build better workflows for the industry, and deliver meaningful decisions in drugs production and healthcare.